BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14610183)

  • 1. The differential requirement for cyclin-dependent kinase activities distinguishes two functions of herpes simplex virus type 1 ICP0.
    Davido DJ; Von Zagorski WF; Maul GG; Schaffer PA
    J Virol; 2003 Dec; 77(23):12603-16. PubMed ID: 14610183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0.
    Davido DJ; Leib DA; Schaffer PA
    J Virol; 2002 Feb; 76(3):1077-88. PubMed ID: 11773384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins.
    Schang LM; Rosenberg A; Schaffer PA
    J Virol; 2000 Mar; 74(5):2107-20. PubMed ID: 10666240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases.
    Schang LM; Rosenberg A; Schaffer PA
    J Virol; 1999 Mar; 73(3):2161-72. PubMed ID: 9971799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription.
    Schang LM; Phillips J; Schaffer PA
    J Virol; 1998 Jul; 72(7):5626-37. PubMed ID: 9621021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins.
    Lopez P; Jacob RJ; Roizman B
    J Virol; 2002 Sep; 76(18):9355-67. PubMed ID: 12186918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human neuron-committed teratocarcinoma NT2 cell line has abnormal ND10 structures and is poorly infected by herpes simplex virus type 1.
    Hsu WL; Everett RD
    J Virol; 2001 Apr; 75(8):3819-31. PubMed ID: 11264371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0.
    Everett RD; Rechter S; Papior P; Tavalai N; Stamminger T; Orr A
    J Virol; 2006 Aug; 80(16):7995-8005. PubMed ID: 16873256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The replication defect of ICP0-null mutant herpes simplex virus 1 can be largely complemented by the combined activities of human cytomegalovirus proteins IE1 and pp71.
    Everett RD; Bell AJ; Lu Y; Orr A
    J Virol; 2013 Jan; 87(2):978-90. PubMed ID: 23135716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruitment of herpes simplex virus type 1 transcriptional regulatory protein ICP4 into foci juxtaposed to ND10 in live, infected cells.
    Everett RD; Sourvinos G; Orr A
    J Virol; 2003 Mar; 77(6):3680-9. PubMed ID: 12610143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency.
    Halford WP; Weisend C; Grace J; Soboleski M; Carr DJ; Balliet JW; Imai Y; Margolis TP; Gebhardt BM
    Virol J; 2006 Jun; 3():44. PubMed ID: 16764725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins.
    Schang LM; Bantly A; Knockaert M; Shaheen F; Meijer L; Malim MH; Gray NS; Schaffer PA
    J Virol; 2002 Aug; 76(15):7874-82. PubMed ID: 12097601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection: localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of ND10-like complexes.
    Everett RD; Sourvinos G; Leiper C; Clements JB; Orr A
    J Virol; 2004 Feb; 78(4):1903-17. PubMed ID: 14747555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization by live-cell microscopy of disruption of ND10 during herpes simplex virus type 1 infection.
    Everett RD; Zafiropoulos A
    J Virol; 2004 Oct; 78(20):11411-5. PubMed ID: 15452264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICP0 dismantles microtubule networks in herpes simplex virus-infected cells.
    Liu M; Schmidt EE; Halford WP
    PLoS One; 2010 Jun; 5(6):e10975. PubMed ID: 20544015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival.
    Hobbs WE; Brough DE; Kovesdi I; DeLuca NA
    J Virol; 2001 Apr; 75(7):3391-403. PubMed ID: 11238865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of fluorescence microscopy to study the association between herpesviruses and intrinsic resistance factors.
    Everett RD
    Viruses; 2011 Dec; 3(12):2412-24. PubMed ID: 22355446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies.
    Tavalai N; Stamminger T
    Viruses; 2009 Dec; 1(3):1240-64. PubMed ID: 21994592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSV-1 ICP0 dimer domain adopts a novel β-barrel fold.
    McCloskey E; Kashipathy M; Cooper A; Gao P; Johnson DK; Battaile KP; Lovell S; Davido DJ
    Proteins; 2024 Feb; ():. PubMed ID: 38372168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSV-1 ICP0 Dimer Domain Adopts a Novel β-barrel Fold.
    McCloskey E; Kashipathy M; Cooper A; Gao P; Johnson DK; Battaile KP; Lovell S; Davido DJ
    bioRxiv; 2024 Jan; ():. PubMed ID: 38293217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.